Why he matters in this case
Prof. Allegaert is the Belgian signatory to the Panel report. KU Leuven is one of Europe’s leading medical-research universities, and his specific research focus on neonatal pharmacology adds a distinctive dimension to the Panel’s case-by-case review. Several indicted collapses involved questions about drug dosing, feed tolerance, and medication administration; a senior neonatal pharmacologist’s reading of those questions brings calibration that a general neonatologist would not.
Professional background
- Professor of Paediatrics, KU Leuven.
- Substantial peer-reviewed publication record in neonatal pharmacology, drug disposition in preterm infants, and evidence synthesis for neonatal care.
- Member of the Shoo Lee International Expert Panel.
What his contribution adds
A neonatal pharmacologist’s reading of insulin-pattern evidence, and of the drug and feed-related strands of the indicted cases, brings a specific technical precision. The Panel’s finding that insulin evidence does not meet a forensic standard, and that feeding-pattern and dosing-related claims do not support deliberate harm, is reinforced by having a signatory with deep pharmacological expertise.